Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors have?

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors has 50 citations in the OpenAlex counts ScholarIQ stores.

When was Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors published?

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors has 2019 year in the ScholarIQ index.

What is the open-access status of Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors?

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors has gold oa status in the ScholarIQ index.

What is the DOI of Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors?

The DOI for Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors is on the source record.

What is the PMID of Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors?

The PMID for Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors is on the source record.

What is the OpenAlex record for Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors?

The OpenAlex for Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors is on the source record.